During chronic infection, these PD1+ T cells represent an exhausted state of T cells 38, probably leading to decreased tumor responses to anti-PD1 immunotherapy, as relatively low tumor response to PD1 inhibitor pembrolizumab is observed in HCC with HBV infection or HCV infection 28. Here, PDCD1 is linked to neoplasm.